|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
JPH04500203A
(ja)
|
1988-08-25 |
1992-01-16 |
ザ リポソーム カンパニー,インコーポレイテッド |
インフルエンザワクチンおよび新規なアジュバント
|
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
CA2006700A1
(en)
|
1989-01-17 |
1990-07-17 |
Antonello Pessi |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
HU212924B
(en)
|
1989-05-25 |
1996-12-30 |
Chiron Corp |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
KR920703114A
(ko)
|
1989-07-14 |
1992-12-17 |
원본미기재 |
접합체 백신을 위한 시토킨 및 호르몬 운반체
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
GB2276169A
(en)
|
1990-07-05 |
1994-09-21 |
Celltech Ltd |
Antibodies specific for carcinoembryonic antigen
|
|
DE69113564T2
(de)
|
1990-08-13 |
1996-05-30 |
American Cyanamid Co |
Faser-Hemagglutinin von Bordetella pertussis als Träger für konjugierten Impfstoff.
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
EP0671948B1
(en)
|
1992-06-25 |
1997-08-13 |
SMITHKLINE BEECHAM BIOLOGICALS s.a. |
Vaccine composition containing adjuvants
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
EP0796326A4
(en)
|
1994-10-24 |
2000-01-19 |
Ophidian Pharm Inc |
VACCINE AND ANTITOXIN FOR THE TREATMENT AND PREVENTION OF C. DIFFICILE DISEASE
|
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
|
WO1997002836A1
(en)
|
1995-07-07 |
1997-01-30 |
Oravax, Inc. |
Clostridium difficile toxins as mucosal adjuvants
|
|
US5707829A
(en)
|
1995-08-11 |
1998-01-13 |
Genetics Institute, Inc. |
DNA sequences and secreted proteins encoded thereby
|
|
CA2296765A1
(en)
|
1996-08-28 |
1998-03-05 |
Ophidian Pharmaceuticals, Inc. |
Soluble recombinant botulinum toxin proteins
|
|
WO1998040100A1
(en)
|
1997-03-10 |
1998-09-17 |
Ottawa Civic Loeb Research Institute |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT
|
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
AU746859B2
(en)
*
|
1997-06-20 |
2002-05-02 |
Imperial College Of Science, Technology And Medicine |
Immonogenic fragments of toxin a of clostridium difficile
|
|
EP1009382B1
(en)
|
1997-09-05 |
2003-06-18 |
GlaxoSmithKline Biologicals S.A. |
Oil in water emulsions containing saponins
|
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
|
AU759391B2
(en)
|
1998-02-12 |
2003-04-10 |
Wyeth Holdings Corporation |
Pneumococcal and meningococcal vaccines formulated with interleukin-12
|
|
US6303114B1
(en)
|
1998-03-05 |
2001-10-16 |
The Medical College Of Ohio |
IL-12 enhancement of immune responses to T-independent antigens
|
|
EP1069910A1
(en)
|
1998-04-09 |
2001-01-24 |
GlaxoSmithKline Biologicals S.A. |
Adjuvant compositions
|
|
US20020009429A1
(en)
*
|
1999-01-29 |
2002-01-24 |
Galagen, Inc. |
Pharmaceutical composition comprising a selected antigen and candida species antigen and methods
|
|
DK1163000T3
(da)
|
1999-03-19 |
2008-04-28 |
Glaxosmithkline Biolog Sa |
Vacciner imod antigener fra bakterier
|
|
CA2365915C
(en)
|
1999-04-09 |
2015-11-24 |
Techlab, Inc. |
Recombinant toxin a/toxin b vaccine against clostridium difficile
|
|
US6733760B1
(en)
*
|
1999-04-09 |
2004-05-11 |
Techlab, Inc. |
Recombinant toxin A/toxin B vaccine against Clostridium difficile
|
|
EP1165796A2
(en)
|
1999-04-09 |
2002-01-02 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
|
AU2001258107A1
(en)
*
|
2000-05-10 |
2001-11-20 |
Glycodesign Inc. |
Designing modulators for glycosyltransferases
|
|
ES2330083T3
(es)
|
2000-10-27 |
2009-12-04 |
Novartis Vaccines And Diagnostics S.R.L. |
Acidos nucleicos y proteinas de estreptococos de los grupos a y b.
|
|
US20040107461A1
(en)
*
|
2001-03-30 |
2004-06-03 |
Padma Commuri |
Glucan chain length domains
|
|
WO2003024480A2
(en)
|
2001-09-14 |
2003-03-27 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
ES2335979T3
(es)
|
2001-09-14 |
2010-04-07 |
Cytos Biotechnology Ag |
Empaquetamiento de cpg inmunoestimuladores en particulas similares a virus: metodo de preparacion y su uso.
|
|
US7226597B2
(en)
|
2002-06-17 |
2007-06-05 |
The Board Of Regents Of The University Of Oklahoma |
Mutants of Clostridium difficile toxin B and methods of use
|
|
US20040235139A1
(en)
*
|
2002-12-23 |
2004-11-25 |
Demain Arnold L. |
Clostridium difficile culture and toxin production methods
|
|
PL2857418T3
(pl)
|
2004-02-06 |
2017-10-31 |
Univ Massachusetts |
Przeciwciała przeciw toksynom Clostridium difficile i ich zastosowania
|
|
US20090087478A1
(en)
|
2004-12-27 |
2009-04-02 |
Progenics Pharmaceuticals (Nevada), Inc. |
Orally Deliverable and Anti-Toxin Antibodies and Methods for Making and Using Them
|
|
US20060228369A1
(en)
|
2005-04-11 |
2006-10-12 |
Program For Appropriate Technology In Health |
Stabilization and preservation of temperature-sensitive vaccines
|
|
US8852600B2
(en)
|
2006-06-08 |
2014-10-07 |
The Rockefeller University |
Codon-optimized DNA molecules encoding the receptor binding domains of Clostridium difficile toxins A and B, and methods of use thereof
|
|
ES2507553T3
(es)
|
2006-08-02 |
2014-10-15 |
Johannes Gutenberg-Universität Mainz |
Fármaco contra intoxicaciones por LCT
|
|
AU2008263591C1
(en)
*
|
2007-06-14 |
2013-09-26 |
The Secretary Of State For Health |
Chemically modified peptides with improved immunogenicity
|
|
WO2008156676A1
(en)
*
|
2007-06-15 |
2008-12-24 |
President And Fellows Of Harvard College |
Methods and compositions for detecting and modulating o-glycosylation
|
|
WO2010017383A1
(en)
|
2008-08-06 |
2010-02-11 |
Emergent Product Development Uk Limited |
Vaccines against clostridium difficile and methods of use
|
|
CA2752815A1
(en)
|
2009-02-20 |
2010-08-26 |
Health Protection Agency |
Antibodies to clostridium difficile toxins
|
|
JP2013503198A
(ja)
*
|
2009-08-27 |
2013-01-31 |
シナプティック リサーチ,リミテッド ライアビリティ カンパニー |
人工多能性幹(iPS)細胞または組織特異的細胞を誘導するための新規タンパク質送達系
|
|
US10046040B2
(en)
|
2009-11-16 |
2018-08-14 |
University Of Maryland, Baltimore |
Multivalent live vector vaccine against Clostridium difficile-associated disease
|
|
WO2011063346A1
(en)
|
2009-11-20 |
2011-05-26 |
Northshore University Health System Research Institute |
Targeting of the c-terminal segment of c. difficile toxin b for improved clinical diagnosis, prevention, and treatment
|
|
CA2782406A1
(en)
*
|
2009-12-02 |
2011-06-09 |
Tufts University |
Atoxic recombinant holotoxins of clostridium difficile as immunogens
|
|
GB0921288D0
(en)
|
2009-12-04 |
2010-01-20 |
Health Prot Agency |
Therapies for preventing or suppressing clostridium difficile infection
|
|
BR112012024898A2
(pt)
|
2010-03-30 |
2015-10-06 |
Pfenex Inc |
expressão de nível elevado de proteínas recombinantes de toxinas
|
|
AU2011239470B2
(en)
*
|
2010-04-15 |
2015-09-10 |
Progenics Pharmaceuticals, Inc. |
Antibodies for the treatment of Clostridium difficile-associated infection and disease
|
|
CN103957931B
(zh)
|
2010-09-03 |
2017-10-24 |
瓦尔内瓦奥地利有限责任公司 |
艰难梭状芽胞杆菌毒素a和毒素b蛋白的分离多肽及其用途
|
|
US8431361B2
(en)
|
2010-09-17 |
2013-04-30 |
Board Of Regents Of The University Of Oklahoma |
Bacterial cells, optimized nucleotide sequences and methods for improved expression of recombinant Clostridium difficile toxin B
|
|
GB201016742D0
(en)
*
|
2010-10-05 |
2010-11-17 |
Health Prot Agency |
Clostridium difficile antigens
|
|
WO2012118693A1
(en)
|
2011-02-28 |
2012-09-07 |
Northshore University Healthsystem |
Methods of diagnosing clostridium difficile infection
|
|
TWI815599B
(zh)
|
2011-04-22 |
2023-09-11 |
美商惠氏有限責任公司 |
與難養芽胞梭菌(Clostridium difficile)之突變毒素有關之組成物及彼之方法
|
|
ES2615737T3
(es)
*
|
2011-05-27 |
2017-06-08 |
Glaxosmithkline Biologicals S.A. |
Composición inmunogénica
|
|
AR087716A1
(es)
*
|
2011-08-31 |
2014-04-09 |
Valent Biosciences Corp |
Composiciones reguladoras del crecimiento de plantas, metodos de preparacion y usos de las mismas
|
|
AR089797A1
(es)
*
|
2012-01-27 |
2014-09-17 |
Merck Sharp & Dohme |
Vacunas contra clostridum difficile que comprenden toxinas recombinantes
|
|
GB201223342D0
(en)
*
|
2012-12-23 |
2013-02-06 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|